Sanofi India Limited has informed the Exchange about Copy of Newspaper Publication of Financial Results for the quarter ended 31st March 2025, as published in Business Standard and Sakal newspapers.
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi India Limited has submitted copies of the newspaper publication of its financial results for the fourth quarter of FY25 (quarter ended 31st March 2025) to the stock exchanges. The results were published on 15th May 2025 in Business Standard (English) and Sakal (Marathi) newspapers. This is a routine compliance filing made under Regulation 30 and 47 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The actual financial numbers are not included in this filing — only confirmation that the results were published in newspapers as required. The letter was signed by Arjun Thakkar, Company Secretary and Compliance Officer.
This is a standard regulatory disclosure and does not contain any new financial information beyond what was already published. There is no direct impact on shareholders or the stock price from this filing alone, though investors can refer to the published Q4 FY25 results in Business Standard or Sakal for the actual numbers.